Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study.

Abstract

Thirty patients with definite or probable chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) of chronic progressive (16 patients) or relapsing (14 patients) course were randomly assigned to receive intravenous immunoglobulin (IvIg) 0.4 g per kg body weight or a placebo treatment on 5 consecutive days in a double-blind, cross-over trial… (More)

Topics

4 Figures and Tables

Cite this paper

@article{Hahn1996IntravenousIT, title={Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study.}, author={A. F. Hahn and Charles F. Bolton and Douglas W Zochodne and Thomas E. Feasby}, journal={Brain : a journal of neurology}, year={1996}, volume={119 ( Pt 4)}, pages={1067-77} }